Our Work

Key Initiatives

The Foundation for NIH, as part of its portfolio, manages several large biomedical research partnerships or Key Initiatives. These partnerships leverage the resources of the National Institutes of Health with the public and private sectors, including government agencies, industry, academia, foundations, associations, and the philanthropic community.

Lung-MAPLung-MAP

A unique public-private collaboration has launched the Lung Cancer Master Protocol (Lung-MAP) trial, a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles.
spacer

Accelerating Medicines Partnership, AMPAccelerating Medicines Partnership

The Accelerating Medicines Partnership (AMP) is a bold new venture between the National Institutes of Health, 10 biopharmaceutical companies and several non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets of disease. Through the FNIH, AMP partners will invest more than $230 million over five years in the first projects, which focus on Alzheimer’s disease, type 2 diabetes, and the autoimmune disorders rheumatoid arthritis and systemic lupus erythematosus (lupus).

Biomarkers ConsortiumThe Biomarkers Consortium

This groundbreaking initiative expands the science of personalized medicine. The study of biomarkers creates the potential to individualize medical treatment by determining how a drug works in the body and identifying patients likely to respond to targeted medicines and therapies.

GCGHGrand Challenges in Global Health

Funded by the Gates Foundation, Grand Challenges in Global Health encompasses 43 project across 33 countries, working toward scientific breakthroughs to prevent, treat, and cure diseases that kill millions each year.
spacer

MAL-EDMAL-ED: A Global Network for the Study of Malnutrition and Enteric Diseases

Poor nutrition is linked to more than half of all child deaths worldwide. This initiative, funded by the Gates Foundation, draws together an international group of science investigators to study the inter-relationship between enteric infections and malnutrition to reduce its devastating effects.

CTC-VIMCCTC-VIMC: Supporting the Development of a Vaccine for HIV/AIDS

The Foundation for NIH is one of 19 consortia comprising the Collaboration for AIDS Vaccine Discovery. Funded by the Gates Foundation, this initiative is aimed toward developing an effective AIDS vaccine.

Football playersThe Sports and Health Research Program (SHRP)

The Sports and Health Research Program (SHRP) is an innovative partnership among the National Institutes of Health (NIH), the National Football League (NFL) and the FNIH. Launched in 2012, the program aims to help accelerate the pursuit of research to enhance the health of athletes at all levels, past, present and future, and to extend the impact of that research beyond the playing field to benefit others in the general population, including members of the military.

Photo courtesy of Mitch Loeber under the Creative Commons license